HM
HealthCor Management Portfolio holdings
AUM
$109M
This Quarter Return
+0.47%
1 Year Return
+11.46%
3 Year Return
+50.01%
5 Year Return
+144.68%
10 Year Return
–
AUM
$2.58B
AUM Growth
+$2.58B
(-3.2%)
Cap. Flow
-$153M
Cap. Flow
% of AUM
-5.92%
Top 10 Holdings %
Top 10 Hldgs %
58.51%
Holding
45
New
7
Increased
14
Reduced
12
Closed
8
Top Buys
| 1 |
Zimmer Biomet
ZBH
|
$139M |
| 2 |
Johnson & Johnson
JNJ
|
$88.8M |
| 3 |
AGN
Allergan plc
AGN
|
$74.7M |
| 4 |
Tenet Healthcare
THC
|
$74.5M |
| 5 |
Incyte
INCY
|
$69.9M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$201M |
| 2 |
BIVV
Bioverativ Inc. Common Stock
BIVV
|
$133M |
| 3 |
Edwards Lifesciences
EW
|
$94.2M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$87.2M |
| 5 |
Cardinal Health
CAH
|
$84.5M |
Sector Composition
| 1 | Healthcare | 90.24% |
| 2 | Financials | 6.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Labcorp
LH
$23.1B
| $237M | 7.95% | 1,572,290 +197,290 | +14% | +$29.8M |
|
|
BIVV
2
DELISTED
Bioverativ Inc. Common Stock
BIVV
| $237M | 7.94% | 4,150,000 -2,325,000 | -36% | -$133M |
|
|
3
Zimmer Biomet
ZBH
$21B
| $198M | 6.64% | 1,692,810 +1,185,380 | +234% | +$139M |
|
|
AET
4
DELISTED
Aetna Inc
AET
| $180M | 6.03% | 1,131,674 +231,674 | +26% | +$36.8M |
|
5
Neurocrine Biosciences
NBIX
$13.8B
| $128M | 4.29% | 2,087,110 -463,068 | -18% | -$28.4M |
|
|
MNK
6
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $120M | 4.03% | 3,214,679 +812,329 | +34% | +$30.4M |
|
|
AGN
7
DELISTED
Allergan plc
AGN
| $117M | 3.94% | 573,210 +364,510 | +175% | +$74.7M |
|
8
Danaher
DHR
$147B
| $107M | 3.6% | 1,251,960 -150,380 | -11% | -$12.9M |
|
9
Pacira BioSciences
PCRX
$1.2B
| $96.8M | 3.24% | 2,578,040 +784,241 | +44% | +$29.4M |
|
|
10
Johnson & Johnson
JNJ
$427B
| $88.8M | 2.98% | +683,050 | New | +$88.8M |
|
11
AbbVie
ABBV
$372B
| $87.6M | 2.94% | 986,320 +186,890 | +23% | +$16.6M |
|
|
CELG
12
DELISTED
Celgene Corp
CELG
| $79.2M | 2.65% | 543,180 -1,381,820 | -72% | -$201M |
|
13
UnitedHealth
UNH
$281B
| $75M | 2.51% | 382,990 +279,890 | +271% | +$54.8M |
|
|
14
Tenet Healthcare
THC
$16.3B
| $74.5M | 2.5% | +4,531,932 | New | +$74.5M |
|
|
15
Incyte
INCY
$16.5B
| $69.9M | 2.34% | +598,550 | New | +$69.9M |
|
16
LivaNova
LIVN
$3.08B
| $65.3M | 2.19% | 931,530 +531,530 | +133% | +$37.2M |
|
17
Haemonetics
HAE
$2.63B
| $65.2M | 2.18% | 1,452,343 -402,529 | -22% | -$18.1M |
|
18
Humana
HUM
$36.5B
| $63.6M | 2.13% | 260,870 +11,772 | +5% | +$2.87M |
|
19
Sarepta Therapeutics
SRPT
$1.78B
| $54.6M | 1.83% | 1,202,770 -829,120 | -41% | -$37.6M |
|
|
CLVS
20
DELISTED
Clovis Oncology, Inc.
CLVS
| $53.3M | 1.79% | 647,420 +401,120 | +163% | +$33.1M |
|
|
SYNH
21
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $48.7M | 1.63% | +930,582 | New | +$48.7M |
|
22
Merck
MRK
$210B
| $44.3M | 1.48% | +691,280 | New | +$44.3M |
|
|
HRC
23
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $43.3M | 1.45% | 584,770 +459,770 | +368% | +$34M |
|
|
FPRX
24
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $41.4M | 1.39% | +1,010,930 | New | +$41.4M |
|
|
25
Edwards Lifesciences
EW
$47.8B
| $37M | 1.24% | 338,490 -861,510 | -72% | -$94.2M |
|